Dechêne, L. (2021). Equine muscle-derived mesenchymal stem cells as cell therapy for osteoarthritis and influence of priming with a hydrosoluble form of curcumin [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/263857 |
Colin, M., Dechêne, L., Ceusters, J., Niesten, A., Demazy, C., Lagneaux, L., Zouaoui Boudjeltia, K., Franck, T., Van Antwerpen, P., Renard, P., Mathieu, V., & Serteyn, D. (2021). Priming of mesenchymal stem cells with a hydrosoluble form of curcumin allows keeping their mesenchymal properties for cell-based therapy development. Journal of Cellular and Molecular Medicine. doi:10.1111/jcmm.16403 Peer Reviewed verified by ORBi |
Graide, H., Ceusters, J., Niesten, A., Dupont, J., Dechêne, L., Nolens, G., & Serteyn, D. (May 2018). Equine muscle-derived stem cells colonize synthetic bone scaffolds [Poster presentation]. First PhD student day in veterinary medicine, Liège, Belgium. |
Ceusters, J., Graide, H., Dupont, J., Dechêne, L., Franck, T., Sandersen, C., Bolen, G., & Serteyn, D. (13 October 2017). Canine muscle derived mesenchymal stem cells: minimally invasive process, characterization and future clinical use [Paper presentation]. 4th FARAH day. |